GEN Exclusives

More »

GEN Poll

More »
Oct 24, 2011

PDUFA V

FDA is getting ready to submit final recommendations for the fifth authorization of the Prescription Drug User Fee Act (PDUFA V) to Congress by January 2012. Details will be shaped by comments to the agency during a day-long public hearing on October 24. The new rules set up a process that emphasizes more communication early on between FDA and sponsors. The hope is that this move will increase the rate of drugs approved on the first try. PDUFA V also allows FDA to collect another $100 million from industry, to reach $3 billion a year. The agency expects to use the money to hire and train more staff to review applications. Read all the details here and tell us what you think about PDUFA V

Do you think FDA’s PDUFA V proposal will improve drug approval rates in the U.S.?

Yes
 
  51.5%
No
 
  27.3%
Undecided
 
  21.2%

More Polls » View Results »

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should the CDC Director Resign?

Do you think the CDC chief should resign?